Clinical Trial

Respiratory Pathogen Distribution During and After the COVID-19 Pandemic

Completed
View on ClinicalTrials.gov →
Summary
This retrospective observational study aims to evaluate changes in the prevalence and distribution of respiratory pathogens detected by multiplex respiratory polymerase chain reaction (PCR) testing during and after the SARS-CoV-2 pandemic. The study includes 537 patients presenting with respiratory infection symptoms at a tertiary care center. Patients were divided into pandemic-period and post-pandemic-period groups, and respiratory pathogen profiles were compared between the groups. The study investigates the epidemiological impact of COVID-19-related public health measures on respiratory pathogen circulation patterns, including bacterial and viral respiratory infections. The findings may contribute to improved respiratory infection surveillance, diagnostic strategies, and post-pandemic public health preparedness.
Trial Details
NCT Number NCT07601126
Lead Sponsor Hisar Intercontinental Hospital
Conditions Viral Respiratory Infection (e.g., Influenza), Bacterial Respiratory Infections
Enrollment 537 participants
Start Date 2021-01-01
Primary Completion 2024-12-30 (estimated)
Study Completion 2024-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-22